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Synchrotron-generated 
microbeams induce hippocampal 
transections in rats
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Mathieu2, Herwig Requardt1, Domenico Bucci5, Giacomo Barbone6, Paola Coan6,7, Giuseppe 
Battaglia5, Geraldine Le Duc1, Alberto Bravin  1 & Pantaleo Romanelli8
Synchrotron-generated microplanar beams (microbeams) provide the most stereo-selective irradiation 
modality known today. This novel irradiation modality has been shown to control seizures originating 
from eloquent cortex causing no neurological deficit in experimental animals. To test the hypothesis 
that application of microbeams in the hippocampus, the most common source of refractory seizures, 
is safe and does not induce severe side effects, we used microbeams to induce transections to the 
hippocampus of healthy rats. An array of parallel microbeams carrying an incident dose of 600 Gy was 
delivered to the rat hippocampus. Immunohistochemistry of phosphorylated γ-H2AX showed cell 
death along the microbeam irradiation paths in rats 48 hours after irradiation. No evident behavioral or 
neurological deficits were observed during the 3-month period of observation. MR imaging showed no 
signs of radio-induced edema or radionecrosis 3 months after irradiation. Histological analysis showed a 
very well preserved hippocampal cytoarchitecture and confirmed the presence of clear-cut microscopic 
transections across the hippocampus. These data support the use of synchrotron-generated 
microbeams as a novel tool to slice the hippocampus of living rats in a minimally invasive way, providing 
(i) a novel experimental model to study hippocampal function and (ii) a new treatment tool for patients 
affected by refractory epilepsy induced by mesial temporal sclerosis.
Microscopic arrays of X-ray beams originating from a synchrotron source can induce the equivalent of a micro-
surgical neocortical or hippocampal incision by delivering very high doses of radiation to tissue slices of micro-
scopic thickness. Neurons, glia and axons along the penetration path receive peak doses up to 1000Gy, and die, 
while the very adjacent tissue is exposed to much lower valley doses (less than 6Gy) unable to induce histologi-
cally evident tissue damage1. In essence, synchrotron-generated cortical transections provide a microradiosur-
gical equivalent of multiple subpial transections (MST), a non resective surgical technique developed to treat 
patients with medically-refractory epilepsy involving eloquent cortex2–4. This technique requires the placement of 
vertical incisions through the epileptic cortex in order to cut the horizontal axons responsible of the propagation 
of seizures while preserving the vertical axons subserving neurological functions. The vertical columns working 
as the basic unit of cortical function are disconnected but not injured by MST, allowing the treatment of epileptic 
foci located over sensorimotor or language cortex not amenable to surgical resection. Microbeam transections 
have been performed over an epileptogenic focus located in sensorimotor cortex, with almost immediate aboli-
tion of seizures and excellent preservation of motor function5. These results suggested further investigations to 
assess the potential of microbeam transections to modulate cortical and hippocampal functions and to treat focal 
epilepsy and other brain disorders as well as brain tumors. Further studies on this novel approach have also been 
encouraged by the ongoing development of devices delivering submillimetric beams able to generate the equiv-
alent of a microbeam transections which could be available for clinical testing soon. Microbeam transections 
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might add a powerful new tool to the clinical treatment of epilepsy and, more in general, to modulate cortical 
functions in a wide variety of neuropsychiatric disorders5. There is currently no equivalent to this technique either 
using radiation or microsurgery. Stereotactic radiosurgery, which is the most refined technique to deliver focal 
irradiation, cannot provide currently beams smaller than 4 mm and doses exceeding 100 Gy are often associated 
with severe side effects such as radionecrosis and massive brain edema. Microsurgery provides the ability to 
generate cortical transections of approximately 1 mm size but require a craniotomy and the manipulation of the 
cortex. None of the two allows to change the size of the transections, the distance between the transections, the 
location and extension of the cortical or hippocampal region transected, while this is possible with microbeam 
transections.
Stereotactic radiosurgery (SRS) provides today an attractive less invasive than traditional surgery approach to 
treat cortical, hippocampal or diencephalic epileptic foci but it is limited by the relatively low doses deliverable 
with current techniques, by the long delay needed to achieve seizure amelioration using currently allowed doses 
and by the side effects discussed above (severe radio-induced edema and radionecrosis)6.
As compared with SRS, synchrotron-generated X-ray microplanar beams (microbeams) provide a completely 
new tool to deliver extremely high doses of radiation restricted to microscopic volumes1,5,7,8. The dose spread-
ing outside the beam path is minimal, allowing to release doses of several hundred Gray (Gy) to tissue slices of 
microscopic thickness. Outside the beam path, there is a brisk dose reduction: a few dozen of microns away from 
the beam the dose delivered to the tissue is already less than 5% than the in-beam dose9. This unique irradiation 
modality provides the ability to generate the equivalent of a microsurgical incision in a minimally invasive way. 
Synchrotron microbeams can be delivered with submillimetric precision over a fraction of a second to selected 
brain regions, thus ablating a tumor or an epileptic focus1,5,7,8. The European Synchrotron Radiation Facility 
(ESRF, Grenoble, France) has provided us a unique tool to treat experimental epilepsy by generating microbeam 
transections in eloquent brain regions5. We have explored the ability of microbeams to generate cortical and 
hippocampal transections by delivering peak doses ranging from 150 to 600 Gy to microscopic brain volumes of 
75 to 600 µm in thickness. We have observed that spatially restricted microbeam irradiation, even delivered at 
high-dose, provides an exceptional degree of protection from radio-induced damage to neurons and glial cells 
adjacent to the microscopic slices of irradiated cortex and hippocampus. Microbeam transections have been 
generated within an epileptic focus located in eloquent cortex to test their ability to abolish seizures while pre-
serving neurological function5. Seizure control was thus achieved in rats with status epilepticus generated by focal 
injection of kainic acid in the sensorimotor cortex. The sensorimotor cortex transections generated no motor 
deficits. This experimental work confirmed that microbeam transection can stop seizures while preserving the 
function of the irradiated cortex10. However, the origin of most cases of drug-refractory seizures in adult patients 
is the hippocampus vs. the neocortex. Accordingly, we tested the hypothesis that microbeams irradiation of the 
hippocampus is safe and does not induce severe side effects in healthy rats.
Results
Dosimetry. The dose profile into the target consists of high doses along the microbeam path (peak) and low 
doses in the spaces between them (valley) (Fig. 1A). A measured dose profile in homogeneous water is visible in 
Fig. 1A; the profile was acquired following the protocol described in Bräuer-Krisch et al.11. The microbeam field 
contains 9 parallel 75 µm wide and 2 mm high microbeams with a center-to-center spacing of 400 µm, delivered 
following the coordinated reported in the Methods section and illustrated in Fig. 1B and C. In MRT, the reference 
valley dose is normally assumed as the minimum dose in between two microbeams. Figure 2A shows peak to val-
ley dose ratios (PVDR), Fig. 2B peak and Fig. 2C valley dose on respectively axial and coronal views. The dose is 
normalized such that the peak dose would be 600 Gy at 3 mm depth in a homogeneous water phantom. The peak 
dose is between 520 and 590 Gy in the brain, depending on the distance from the beam entrance; the valley dose 
ranges between 6.4 and 6.8 Gy. The PVDR measures between 80 and 87.
Early Immunohistochemistry. Immunohistochemistry of phosphorylated γ-H2AX showed a well-defined 
column of cell death along the microbeam penetration pathway 48 hours after irradiation. There was a brisk 
transition from the nuclei of cells positive for phosphorylated γ-H2AX, a histone modification in response to 
DNA double-strand break, which occurs within minutes of break induction, and is a sign of dying cells along the 
beam path. Figure 3 shows a bright red color for phosphorylated γ-H2AX, and the nuclei of viable cells just a few 
microns away. Inside and near the beam path, we observed early cell proliferation, as detected by immunohisto-
chemistry of Ki67, a marker of proliferating cells. Ki67-positive cells were visible as green-colored nuclei (Fig. 3) 
48 hours after irradiation. The characterization of these cells requires further studies.
Behavioral observations. All rats tolerated very well the procedure. Two animals were randomly chosen 
and sacrificed within 48 hours from irradiation to verify the immediate effects of microbeam transections. The 
remaining 8 rats survived and gained weight regularly during the observation period of 3 months. No sign of 
behavioral abnormalities or neurological disorders was observed during weekly observations.
MR imaging. No sign of irradiation was observed either on T1 post-contrast and T2 imaging carried out 3 
months after microbeam irradiation. T1 post-contrast images show no signal changes and no extravasation of 
contrast medium in the irradiated regions. No sign of radionecrosis was visible (Fig. 4A) and T2 post-contrast 
images were remarkable for the absence of hyperintense signal suggestive of radio-induced hippocampal edema 
(Fig. 4B). Hippocampal volumes and shapes are similar on the irradiated and non-irradiated side. Dorsal hip-
pocampal volumes in irradiated vs. non-irradiated (control) sides were compatible (Fig. 4C).
Histology. Histological analysis carried out 3 months after microbeam irradiation showed clear paths of cell 
death corresponding to the beam penetration pathway (Fig. 5A). These transections were characterized by sharp 
www.nature.com/scientificreports/
3SCIENTIFIC REPoRtS |  (2018) 8:184  | DOI:10.1038/s41598-017-18000-x
margins. Shape and volume of the transected hippocampus and dentate gyrus have normal appearance (Fig. 5B). 
The loss of cells along the irradiation path is almost completely “rescued” as observed at high magnification, 
where normal neurons are visible immediately outside the beam path (Fig. 5C). There is only the presence of these 
transections due to cell loss.
Discussion
Focal irradiation of an epileptic focus through SRS is an emerging treatment for medically refractory seizures, 
providing a non-surgical approach which is mainly limited by the delay of efficacy (several months are typically 
required to obtain seizure relief) and side-effects (long-lasting radio-induced edema requiring prolonged steroid 
Figure 1. Microbeam dosimetry and schematic representation of irradiation geometry. (A) Plot of the lateral 
dose profile in water. (B) Sagittal section of the Paxinos and Watson’s rat brain atlas30 showing the geometry of 
microbeam irradiation. Coronal section of the left hippocampus irradiation is shown in (C). The irradiation of 
the right hippocampus is specular to (C). Arrays of 75 μm thick microbeams (9 beams, center-to-center spacing: 
400 μm) were delivered perpendicular to the dorsal hippocampus (from −3 mm to −5 mm posterior to the 
bregma) using an atlas-based image guided X-ray setup.
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administration)11,12. Current LINAC- or cobalt-based technologies do not allow to deliver high doses to cortical 
slices of millimetric size, thus replicating the exquisite cortical incisions generated by MST. A novel exciting 
approach combining the advantages of SRS and MST has been investigated at the ESRF, where arrays of micropla-
nar beams have been used to generate cortical transections equivalent to MST in a minimally invasive, bloodless 
way.
Romanelli and Bravin1 hypothesized that microbeam cortical transections may be explored as a way to mod-
ulate cortical function without injury to the columnar organization. This technique would have preserved the 
Figure 2. Coronal and axial views of the rat showing peak dose (A), valley dose (B) and peak to valley dose 
ratios (PVDR) (C). Doses are normalized such that the peak dose at 3 mm depth in a homogeneous water 
phantom would be 600 Gy. The microbeam field contains 9 parallel 75 µm wide and 2 mm high microbeams 
with a center-to-center spacing of 400 µm. The peak dose is between 520 and 590 Gy in the brain, depending 
on the distance from the beam entrance; the valley dose ranges between 6.4 and 6.8 Gy. The PVDR measures 
between 80 and 87. The figures overlay Hounsfield units of a computed tomography image acquired at the ESRF 
at 35 keV (in gray) and doses using the color scale on the right.
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vertical axons and transected horizontal seizure-spreading axons, determining an effective way to parcellize a 
neocortical epileptic focus and stop seizure propagation while preserving cortical function. Microbeam tran-
sections of the sensorimotor cortex were then demonstrated to reduce seizure in an epilepsy rat model5,8 and 
video-EEG analysis showed abolition of seizures after the microbeam delivery13. Microbeam transections applied 
to a rat model of absence epilepsy (GAERS rats) also altered the abnormal neuronal activities for at least 9 weeks14.
Here, we show that the dorsal hippocampus was transected with microbeams, where the average dose given to 
the 75 µm column of tissue crossed by a microbeam (peak dose) was >80 times higher than the dose in the tissue 
placed between the paths (valley dose) (see Fig. 2). Neuronal cells, glial cells and axons along the penetration 
path are ablated without damage to adjacent cells, thus originating the equivalent of a microsurgical incision. 
Therefore, synchrotron-generated cortical transections provide a microradiosurgical equivalent of MST, which, 
however, requires an invasive procedure involving all the risks related to open surgery. Microbeam transections 
are performed in a minimally invasive way and the size and spacing of the transections can be modified by the 
surgeon according to the needs. The histological effects of hippocampal transection have been investigated here 
in healthy rats showing no MR signal changes, radioinduced edema and radionecrosis, and excellent preserva-
tion of the hippocampal architecture after 3 months. Immunohistochemistry performed immediately after the 
irradiation showed immediate cell death along the microbeam path with proliferative response within the path 
itself and in the immediately adjacent tissue. This observation shows that a high-dose (in the range of hundreds 
of Gy) stereoselective irradiation restricted to volumes of microscopic size allows cell replication over the imme-
diately adjacent tissue, visible after 48 hours. The marker used here (Ki67) does not allow to verify the glial versus 
neuronal origin of the replicating cells but the induction of neural progenitor proliferation cannot be excluded 
Figure 3. Microbeams induce early cell death. Immunohistochemistry of phosphorylated γ-H2AX-positive 
cells (in red) and Ki67-positive cells (in green) in the rat dorsal hippocampus 48 hours after microbeam 
irradiation (A). Magnification of the square in A (B). Ki67-positive cells are visible within and between the 
microbeam path (C). Higher magnification of C (D).
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and we are working to further characterize this proliferative response. In humans, radio-induced edema and 
radionecrosis develop 6 to 12 months after irradiation (even if late radionecrosis is possible, especially with con-
ventional radiotherapy). An experimental study to assess toxicity on primates of conventional irradiation (total 
dose: 40 Gy delivered in 8 fractions, of 5 Gy each, over one month) lead to the sacrifice of all the animals 6 months 
after the irradiation due to severe consequences of edema and radionecrosis15. Considering the exceptionally high 
doses used here (600 Gy delivered in 0.17 s), we observed parallel cuts immediately and 3 months after irradiation 
through the hippocampus, providing an “elegant” slicing of the region. After 3 months, MRI and conventional 
histology confirmed the total absence of radio-induced edema and/or radionecrosis. On the contrary, studies on 
hippocampal irradiation using conventional stereotactic radiosurgery after lower doses have shown extensive 
MRI and histological changes with massive radionecrosis and extensive radio-induced edema at this time point. 
In another study16, rats received stereotactic unilateral hippocampal irradiation with doses ranging from 5 to 
130 Gy and evaluation by T2 MRI showed evidence of radio-induced edema and radionecrosis in rats receiving 
90 and 130 Gy at 3 months. Mori et al.17 have performed MRI with T1- and T2-weighted series in rats 7, 21 and 
42 days after hippocampal injection of kainic acid followed by stereotactic radiosurgery delivering doses of 20, 
40, 60 and 100 Gy. Hippocampal injury related to kainic acid injection was found in all cases, but evidence of 
additional radionecrosis was found in rats irradiated with 100 Gy. Finally, Ishikawa et al.18 have shown widespread 
radio-induced edema (visible on T1 and T2-weighted MRI performed 2 weeks after irradiation) in rats receiving 
200 Gy and sacrificed after 2 weeks. In rats receiving lower doses (100, 75, 50, 25 Gy), MRI was done sequentially 
every two weeks up to 16 weeks when rats were sacrificed for histological analysis. Evidence of radionecrosis and 
edema were found on MRI in 200 Gy irradiated rats extending along the white matter to the ipsilateral thalamus, 
hypothalamus, striatum, and to the contralateral external capsule. Similar findings developed 8–10 weeks after 
irradiation with 100 Gy. Rats receiving 75, 50 and 25 Gy developed less striking changes but MRI was still remark-
able for radionecrosis and radio-induced edema, confirmed by histological analysis carried out 4 months after 
irradiation. Considering that maximum dose delivered to the hippocampus before our study was 200 Gy (causing 
damage to induce the sacrifice of rats after 2 weeks) and based on the observations of several reports19–22 deliver-
ing stereotactic irradiation to the hippocampus, we set our observation time at 3 months. Our findings are very 
encouraging having found no damage outside the transection 3 months after the delivery of a microbeam array 
carrying an incident dose of 600 Gy with a valley dose of 6.4 Gy. We are now studying whether transections can 
Figure 4. MRI does not show any sign of radionecrosis or radio-induced edema. Representative T1-
weighted post-contrast (A) and T2-weighted (B) MRI performed 3 months after irradiation of the left dorsal 
hippocampus are shown. Blue lines indicate the irradiation zone in the left dorsal hippocampus. Note the 
absence of any sign of brain damage induced by the microbeams (peak dose: 600 Gy). Quantification of left and 
right dorsal hippocampal volumes in control unirradiated rats and in irradiated rats. Values were calculated 
directly from the DICOM images and are the means ±  SD (n = 2–4). Statistical analysis was performed by Two-
Way ANOVA (p = 0.992, irradiation x brain area) (C).
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be obtained with lower doses (150 or 300 Gy), thus lowering the valley doses to levels fully compatible with those 
of human radiation therapy.
In conclusion, our preliminary results are encouraging, suggesting that microbeam transections hold a 
great potential to modulate brain function and to treat focal epilepsy by mimicking MST in a minimally inva-
sive way without carrying out surgery. Moreover, as previously shown5, seizure control and preservation of 
motor function after eloquent cortex transections provide the groundwork for an exciting new application of 
synchrotron-generated microbeams, opening the way to the application of this new concept to the most common 
source of medically-refractory seizures, the hippocampus, responsible of mesiotemporal epilepsy. Therefore, the 
development of novel devices delivering submillimetric beams might add a new powerful tool to the clinical 
treatment of epilepsy and, more in general, to modulate cortical and hippocampal functions in a wide variety of 
neuropsychiatric disorders.
Figure 5. Histological analysis of rat hippocampus 3 months after microbeam-induced transections. Clear-
cut transections through the hippocampus are visible with no evident collateral damage (A). Overlay of 
the histology over the equivalent slice taken from the Paxinos and Watson rat brain atlas. The hippocampal 
architecture is very well preserved (B). The square in the dentate gyrus in (A) is highlighted at higher 
magnification in (C). Note that the hippocampal layers near to the transections are not affected.
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Methods
Animals. Male Wistar rats (175–200 g) were purchased from Charles River Laboratories (L’Arbresle, France) 
and were maintained under controlled environmental conditions (temperature: 22 ± 2 °C, humidity: 40–60%) on 
a 12-hour light/dark cycle with food and water ad libitum.
All experimental protocols related to animal care strictly conformed to the Guidelines of the French 
Government and the 2010/63/UE directive and were approved by the ethical committee of the European 
Synchrotron Radiation Facility, Grenoble. All efforts were made to minimize the potential sufferance and dis-
comfort of animals and their number.
Irradiation parameters. All irradiations were carried out at the ID17 Biomedical Beamline of the ESRF. 
X-rays are emitted by the wiggler source located in the straight section of the storage ring. The wiggler produces 
a continuous (white) beam spectrum filtered for this study by a succession of five attenuators [Be (0.5 mm), C 
(1.5 mm), Al (1.5 mm), Cu (1.0 mm) and Al (1.5 mm)] resulting in a photon spectrum extending from about 50 to 
350 keV, with a mean energy of approximately 105 keV10. The quasi-laminar beam is spatially fractionated into an 
array of microbeams of variable size by using an adjustable multislit collimator23. The X-ray fluence produced by 
the wiggler determined an entrance dose rate of around 14,000 Gy/s in the homogeneous 2 × 2 cm2 field, allowing 
the deposition in a fraction of second of doses of hundreds of Grays along the microscopic planes.
Animals were irradiated with a microbeam array made by 9 parallel microbeams of 75 µm in width (as full 
width at half maximum) and 400 µm center-to-center distance. Before irradiation, each microbeam was individ-
ually measured using a ~1–1.5 µm wide tungsten aperture moved in front of it; the signal was then recorded by 
an ionization chamber. The microbeam size was highly homogeneous and a maximum difference of ±1 µm was 
measured between the beams thanks to the regular geometry of the collimator.
The irradiation target was identified on low dose (<5 mGy) radiographies performed using a highly attenu-
ated beam. High resolution images (22 μm pixel size) were acquired by a Frelon camera-based detection system24 
using the propagation-based phase contrast technique25. This method allowed a precise determination of the 
bregma (uncertainly: < 0.2 mm), which was the origin of the rat coordinates.
Monte Carlo dosimetry simulation. The dose distribution was calculated using the Monte Carlo toolkit 
Geant4, version 10.2.2. based on a CT of a rat acquired at 35 keV at the synchrotron. Hounsfield units were trans-
lated into material composition and density using the method of Schneider et al.26. For the spectrum at the ESRF 
photoelectric effect, Compton scattering and Rayleigh scattering are relevant and taken into account. Cut-off 
ranges for electrons were set to 1 µm. Energy absorption was scored independently for peak and valley on grid 
defined by the CT cube27. Valley dose is defined as average dose in the central 60% (195 µm) of the valley and 
peak dose as average dose in the central 80% (60 µm) of the peak. A total number of 2.109 primary photons were 
simulated according to a phase space model that incorporates polarization, collimator absorption and leakage 
radiation28.
Irradiation of rats. Rats were anesthetized with an intraperitoneal injection of xylazine/ketamine 
(64.5/5.4 mg*kg−1) for unilateral irradiation of the dorsal hippocampus using a microbeam array. Five animals 
received right hippocampal transections and 5 animals underwent left hippocampal transections. Anesthetized 
rats were placed in vertical prone position on a custom-made stereotactic frame fixed on the Kappa goniometer 
(Huber, Germany), which allows to translate and rotate the animal in front of the fixed horizontal X-ray beam29. 
The spatial configuration of microbeams was checked by Gafchromic® film. The left dorsal hippocampus received 
a microbeam array measuring 2 mm in the antero-posterior (AP) direction (3 to 5 mm posterior to the bregma) 
and 3.6 mm in the mediolateral (ML) direction (−1 to −4.3 mm lateral to the midline)30. The right hippocampus 
received an identical irradiation (coordinates: AP: 3 to 5 mm posterior to bregma; ML: 1 to 4.3 lateral to midline).
Behavior assessment. Rats were weighed weekly and observed daily to evaluate the development of behav-
ioral and physiological abnormalities and signs of pain and distress (e.g. weight loss, aggressiveness, apathy, hemi-
paresis, lethargy).
Magnetic Resonance Imaging (MRI) acquisition. Magnetic resonance imaging (MRI) was performed 
at the MRI platform of the Grenoble Institute of Neurosciences (Grenoble, France) 3 months after irradiation 
on 2 non-irradiated rats and 4 irradiated rats. Rats were anesthetized by isoflurane (5% for induction and 2.5% 
for maintenance) for MRI studies. Images were acquired using a 7 T Bruker Avance III system using a quadra-
ture volume coil. A T2-weighted sequence (acquisition parameters, according to Serduc et al.31, were TR: 4000 
ms, effective TE: 33 ms, FOV: 30 × 30 mm2, matrix: 256 × 256, slice thickness: 0.5 mm, N average = 2, duration 
4 min 16 s) was acquired to visualize the hippocampal anatomy bilaterally and check for radio-induced edema 
and/or radionecrosis. A T1-weighted post-contrast sequence (acquisition parameters, according to Pouyatos et 
al.14, were TR: 1300 ms, effective TE: 7.7 ms, FOV: 30 × 30 mm2, matrix: 256 × 256, slice thickness: 0.5 mm, 
N average = 4, duration 4 min 4 s) was then acquired 5 min after an intravenous injection of Gd-DOTA (200 
µmol*kg−1, Dotarem, Guebert®, France) to verify evidence of contrast extravasation following radiation damage 
of the blood-brain barrier.
Image processing. The dorsal hippocampal volumes were computed from the DICOM images by manually high-
lighting the target area multiplied by slice thickness using the MicroDicom viewer software (www.microdicom.com).
Immunohistochemistry and histology. Forty-eight hours or 3 months after irradiation rats were killed 
by intraperitoneal administration of a Dolethal® overdose. Brains were dissected out and immediately frozen at 
−20 °C or fixed in 4% paraformaldeide (PFA). Fifteen µm thin coronal brain sections were cut at −22 °C on a 
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cryostat and stained with thionin (Nissl staining). For immunohistochemistry, 15 µm thin coronal brain sections 
were cut on a microtome. Slices were blocked with donkey normal serum (DNS, Interchim) in phosphate-buffered 
saline (PBS) 1X for one hour (PBS/DNS 5%). Primary antibodies were anti-phosphorylated γ-H2AX (1/500, 
05636, Upstate Biotechnology, Lake Placid, NY) and Ki67 (1/200, Clone S6, Lab Vision Corporation, Fremont, 
CA) diluted in PBS/NDS 1%. Sections were washed 4 times with PBS, then incubated with the secondary anti-
bodies Alexa fluor-conjugated donkey F(ab’)2 (1/200, #A31571 and #A11056, Invitrogen, Carlsbad, CA) for 2 h at 
room temperature. Sections were examined with a Nikon Eclipse E600 microscope equipped for epifluorescence.
Statistical analysis. Data were analyzed by Two-Way ANOVA.
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